The economics of benign prostatic hyperplasia treatment: a literature review
- 31 December 1996
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (6), 1227-1241
- https://doi.org/10.1016/s0149-2918(96)80078-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasiaUrology, 1996
- Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasiaUrology, 1995
- THE DEVELOPMENT AND CLINICAL UTILITY OF SYMPTOM SCORESUrologic Clinics of North America, 1995
- Prostatism and the Burden of Benign Prostatic Hyperplasia on Elderly MenAge and Ageing, 1994
- Evaluation and results of treatments for prostatismUrological Research, 1994
- Urologists On a Tightrope: Coping with a Changing EconomyJournal of Urology, 1994
- Economic Burden of Treated Benign Prostatic Hyperplasia in the United KingdomBritish Journal of Urology, 1993
- Comparison of the Cost-Effectiveness of Various Therapies for Common Prostatic DisordersPharmacoEconomics, 1992
- The prostate: An increasing medical problemThe Prostate, 1990
- Discounting surgical benefitsJournal of Medical Systems, 1983